I. Brick

852 total citations
21 papers, 592 citations indexed

About

I. Brick is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, I. Brick has authored 21 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Physiology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in I. Brick's work include Nitric Oxide and Endothelin Effects (4 papers), Heart Rate Variability and Autonomic Control (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). I. Brick is often cited by papers focused on Nitric Oxide and Endothelin Effects (4 papers), Heart Rate Variability and Autonomic Control (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). I. Brick collaborates with scholars based in Ireland, United Kingdom and Switzerland. I. Brick's co-authors include Ciaran A. O’Boyle, I. C. Roddie, Marie Kenny, K.J. Hutchison, A. Darragh, R. Lambe, Austin Darragh, R.G. Shanks, D. G. McDevitt and Mary Scully and has published in prestigious journals such as The Lancet, The Journal of Physiology and The American Journal of Cardiology.

In The Last Decade

I. Brick

20 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I. Brick Ireland	11	161	143	133	115	106	21	592
M. J. Mattila Finland	18	134 0.8×	189 1.3×	134 1.0×	83 0.7×	81 0.8×	51	816
E. Nuotto Finland	11	78 0.5×	82 0.6×	55 0.4×	135 1.2×	86 0.8×	21	451
J. Rupreht Netherlands	13	106 0.7×	80 0.6×	47 0.4×	180 1.6×	60 0.6×	49	500
A. Doenicke Germany	14	74 0.5×	62 0.4×	68 0.5×	262 2.3×	75 0.7×	73	678
Peter Chodoff United States	12	177 1.1×	84 0.6×	45 0.3×	268 2.3×	98 0.9×	38	859
Patsy Poppleton United Kingdom	8	124 0.8×	227 1.6×	52 0.4×	95 0.8×	29 0.3×	9	478
H D Kleber	7	393 2.4×	89 0.6×	66 0.5×	69 0.6×	35 0.3×	8	697
L. Aaltonen Finland	13	68 0.4×	39 0.3×	80 0.6×	105 0.9×	40 0.4×	27	356
Jürg Schneider United States	17	261 1.6×	58 0.4×	71 0.5×	162 1.4×	121 1.1×	31	1.0k
Alfred L van Steveninck Netherlands	8	188 1.2×	194 1.4×	108 0.8×	93 0.8×	21 0.2×	11	586

Countries citing papers authored by I. Brick

Since Specialization

Citations

This map shows the geographic impact of I. Brick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Brick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Brick more than expected).

Fields of papers citing papers by I. Brick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Brick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Brick. The network helps show where I. Brick may publish in the future.

Co-authorship network of co-authors of I. Brick

This figure shows the co-authorship network connecting the top 25 collaborators of I. Brick. A scholar is included among the top collaborators of I. Brick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Brick. I. Brick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Darragh, Austin, et al.. (1984). Pharmacokinetics and tolerance of enoxacin in healthy volunteers administered at a dosage of 400 mg twice daily for 14 days. Journal of Antimicrobial Chemotherapy. 14(suppl C). 71–74. 12 indexed citations

Lambe, R., et al.. (1983). The effect of PK 5078, a new serotonin uptake inhibitor, on serotonin levels and uptake in human platelets, following administration to healthy volunteers. European Journal of Clinical Pharmacology. 25(1). 23–28. 6 indexed citations

Darragh, Austin, et al.. (1983). Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788. Psychopharmacology. 80(2). 192–195. 59 indexed citations

O’Boyle, Ciaran A., et al.. (1983). RO 15–1788 ANTAGONIZES THE EFFECTS OF DIAZEPAM IN MAN WITHOUT AFFECTING ITS BIOAVAILABILITY. British Journal of Anaesthesia. 55(4). 349–356. 78 indexed citations

Lambe, R., et al.. (1983). Platelet uptake of serotonin following repeated administration of 3-cyano-imipramine to healthy volunteers. Psychopharmacology. 81(4). 357–358. 1 indexed citations

Darragh, A., R. Lambe, Marie Kenny, & I. Brick. (1983). Tolerance of healthy volunteers to intravenous administration of the benzodiazepine antagonist Ro 15-1788. European Journal of Clinical Pharmacology. 24(4). 569–570. 34 indexed citations

Lambe, R., et al.. (1983). Effects of a single oral dose of 3-cyano-imipramine on serotonin uptake and content of platelets in healthy volunteers. Psychopharmacology. 79(4). 304–307. 2 indexed citations

Darragh, A., et al.. (1982). RO 15‐1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.. British Journal of Clinical Pharmacology. 14(5). 677–682. 79 indexed citations

Darragh, A., R. Lambe, I. Brick, & Ciaran A. O’Boyle. (1982). Antagonism of the central effects of 3‐methylclonazepam.. British Journal of Clinical Pharmacology. 14(6). 871–872. 15 indexed citations

10.

Darragh, Austin, et al.. (1981). INVESTIGATION IN MAN OF THE EFFICACY OF A BENZODIAZEPINE ANTAGONIST, Ro 15-1788. The Lancet. 318(8236). 8–10. 91 indexed citations

11.

Brick, I., Karen J. Hutchinson, & I. C. Roddie. (1970). Beta adrenergic blocking properties of D and DL propranolol in man. Irish Journal of Medical Science (1971 -). 3(3). 123–130. 4 indexed citations

12.

Brick, I., K.J. Hutchison, D. G. McDevitt, I. C. Roddie, & R.G. Shanks. (1968). Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. British Journal of Pharmacology. 34(1). 127–140. 106 indexed citations

13.

Brick, I., et al.. (1968). Cardiac adrenergic blockade by 4-(2-hydroxy-3-isopropylamino-propoxy) acetanilide (I.C.I. 50172). Naunyn-Schmiedeberg s Archives of Pharmacology. 259(2). 156–157. 1 indexed citations

14.

Brick, I., et al.. (1967). Differences in cardiovascular responses to adrenaline in recumbent and free-standing man.. PubMed. 191(1). 28P–29P.

15.

Shanks, R.G., I. Brick, K.J. Hutchison, & I. C. Roddie. (1967). Stimulation of adrenergic beta-receptors by orciprenaline.. BMJ. 1(5540). 610–612. 13 indexed citations

16.

Brick, I., Karen J. Hutchinson, & I. C. Roddie. (1967). THE VASODILATOR PROPERTIES OF NORADRENALINE IN THE HUMAN FOREARM. British Journal of Pharmacology and Chemotherapy. 30(3). 561–567. 10 indexed citations

17.

Brick, I., et al.. (1967). Inactivation of circulating catecholamines in the human forearm.. PubMed. 190(2). 25P–26P. 4 indexed citations

18.

Brick, I., K.J. Hutchison, & I. C. Roddie. (1966). The effect of beta adrenergic receptor blockade on the vasodilator response in the forearm to voluntary hyperventilation. The Journal of Physiology. 187(3). 645–649. 6 indexed citations

19.

Brick, I., W. E. Glover, K.J. Hutchison, & I. C. Roddie. (1966). Effects of propranolol on peripheral vessels in man. The American Journal of Cardiology. 18(3). 329–332. 54 indexed citations

20.

Logan, C. J., I. Brick, & I. C. Roddie. (1966). CIRCULATORY EFFECTS OF A SYNTHETIC GASTRIN-LIKE PENTAPEPTIDE (I.C.I. 50,123). The Lancet. 287(7445). 999–1000. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact